Market Cap: $10.23B
Market Cap: $10.23B
Open
$39.49
Prev. Close
$49.81
High
$39.52
Low
$38.72
Qiagen N.V.
Qiagen N.V. trades on the New York Stock Exchange under the ticker QGEN, priced in USD.
Qiagen N.V. has a market capitalisation of $10.23B, based on its latest share price.
QGEN trades at 25.81 times its trailing 12-month earnings.
Over the past 52 weeks QGEN has traded between $32.53 and $57.82.
Yes. Qiagen N.V.'s dividend yields 5.25% at the current share price, paying out 13% of its earnings.
Highly profitable: keeps 19.5% of revenue as net profit.
The analyst consensus rating for QGEN is Hold. Analysts' average 12-month price target of $47.05 implies 5% downside.
Jon Pratt is the CEO of Qiagen N.V., which is headquartered in Venlo.
Generated automatically from reported financial data. General information only, not financial advice.

Qiagen NV (Ticker: QGEN) enhances its QIAcuity digital PCR ecosystem with significant advancements recently announced. The new tools expand gene expression capabilities, allow for improved multiplexin…

Qiagen NV (Ticker: QGEN) makes strides in enhancing its QIAcuity digital PCR ecosystem, focusing on advanced gene expression and automation features designed for high-throughput laboratories. The rece…

In the face of ongoing infectious disease challenges, Qiagen NV (Ticker: QGEN) is making significant strides with the recent launch of research-use-only digital PCR assays aimed specifically at the Bu…

Qiagen NV (Ticker: QGEN) launches new digital PCR assays that target the Bundibugyo ebolavirus, a decisive step in strengthening its portfolio of infectious disease research tools. This launch not onl…